跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84 条关于
“Sumitomo”
全部
84
临床试验
2
药物
34
机构
11
资讯
37
2年前
FDA Accepts Sumitomo Pharma's sNDA for Vibegron in Men with OAB and BPH
去年
Sumitomo Corporation Partners with AI Startup AiRato to Revolutionize Cancer Radiation Therapy Planning
去年
FDA Approves Gemtesa (Vibegron) for Overactive Bladder in Men with BPH
10个月前
Sumitomo Pharma Reports Promising Clinical Data for Enzomenib and Nuvisertib Ahead of ASH 2025
去年
Sound Wave Innovation and Sumitomo Heavy Industries Partner to Advance LIPUS-Brain Device for Alzheimer's Treatment
上个月
Sumitomo Pharma America Doses First Patient in Phase 1/2a Trial of iPSC-Derived Cell Therapy DSP-3077 for Retinitis Pigmentosa
去年
Knight Therapeutics Acquires Sumitomo's Canadian Portfolio Including MYFEMBREE and ORGOVYX for C$25.4 Million
去年
Sumitomo's Novel Schizophrenia Drug Ulotaront Fails to Meet Primary Endpoint in Phase 3 Trials
去年
FDA Grants Fast Track Designation to Sumitomo's Nuvisertib for Myelofibrosis Treatment
7个月前
Poxel Emerges from Judicial Reorganization with Court-Approved Recovery Plan
第 1 页,共 4 页
上一页
下一页